Product
Clotting factor concentrates
1 clinical trial
1 indication
Indication
Hemophilia AClinical trial
An Open-label, Single-arm Treatment Study to Investigate the Safety and Tolerability of Switching From Emicizumab to Fitusiran Prophylaxis in Male Participants Aged ≥18 Years of Age With Severe Hemophilia A, With or Without InhibitorsStatus: Recruiting, Estimated PCD: 2026-09-19